Target intelligence / Profile preview

Selenoprotein active site (Sec-AS)

Target
Sec-AS
Molecular classification
Enzyme, Oxidoreductase, Catalytic site
01

Overview

The selenoprotein active site is a specialized catalytic region characterized by the presence of selenocysteine (Sec), the 21st amino acid (UniProt, 2023). This site is found in a diverse family of approximately 25 human enzymes, including thioredoxin reductases (TrxR) and glutathione peroxidases (GPx), which are essential for maintaining cellular redox homeostasis and protecting against oxidative stress (PubMed, PMID: 29153831). The high nucleophilicity of the selenium atom in Sec makes these active sites exceptionally efficient at catalyzing redox reactions but also renders them highly susceptible to inhibition by electrophilic compounds and heavy metals like gold and arsenic (PubChem, 2024). In therapeutic contexts, targeting the selenoprotein active site—particularly in TrxR—is a strategy used to induce oxidative stress and apoptosis in cancer cells, which often overexpress these enzymes to survive high metabolic demands (PubMed, PMID: 24561143). However, because this site is a conserved structural motif across multiple essential proteins rather than a single unique target, achieving pharmacological selectivity remains a significant challenge (Nature Reviews Drug Discovery, 2018). Consequently, while it is a valid site for drug interaction, the term refers to a class of functional sites rather than a specific individual protein target.

Other names
Selenocysteine catalytic siteSec-containing active siteSelenocysteine residueSelenoprotein redox center
02

Mechanism of action

Covalent modification of the nucleophilic selenocysteine residue, leading to irreversible or reversible enzyme inhibition and disruption of cellular redox balance.

03

Biological functions

Redox homeostasisAntioxidant defenseProtein foldingThyroid hormone metabolismDNA synthesisSelenium transport
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseViral infectionMetabolic disorder
05

Safety considerations

Narrow therapeutic indexOff-target inhibition of multiple essential selenoproteinsPotential for systemic toxicity due to selenium displacementGastrointestinal distressHepatotoxicity at high doses
06

Interacting drugs

Auranofin

5 more in the full profile.

07

Biomarkers

Thioredoxin reductase activityGlutathione peroxidase activitySerum selenium levelsReactive oxygen species (ROS) levelsThioredoxin 1 (Trx1) oxidation state

Beyond the preview

Go deeper on Selenoprotein active site (Sec-AS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selenoprotein active site (Sec-AS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call